JEDIVRA Trademark

Trademark Overview


On Tuesday, August 14, 2018, a trademark application was filed for JEDIVRA with the United States Patent and Trademark Office. The USPTO has given the JEDIVRA trademark a serial number of 88077436. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2020. This trademark is owned by Eli Lilly and Company. The JEDIVRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcera...
jedivra

General Information


Serial Number88077436
Word MarkJEDIVRA
Filing DateTuesday, August 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, August 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019EXTENSION 1 GRANTED
Monday, December 9, 2019EXTENSION 1 FILED
Monday, December 9, 2019TEAS EXTENSION RECEIVED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 6, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 6, 2019ASSIGNED TO LIE
Saturday, March 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 16, 2018NON-FINAL ACTION E-MAILED
Friday, November 16, 2018NON-FINAL ACTION WRITTEN
Friday, November 16, 2018ASSIGNED TO EXAMINER
Wednesday, August 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 17, 2018NEW APPLICATION ENTERED IN TRAM